Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACAD · against 293 other Healthcare companies of similar size
Ranked #119 of 294 · scores higher than 60% of peers · safety percentile 59
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)37 peers with a safety percentile of 50–59, including ACAD · Click a bar to see the companies
A mix: stronger debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ACAD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 289 reported | 0.06× | 0.24× | 75% | 33% | |
| BetaLower is better · 286 reported | 0.89 | 0.55 | 28% | 33% | |
| Current ratioHigher is better · 283 reported | 3.39× | 2.60× | 59% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 1.8B USD | 99 | 42 | |
| 115 | 3.4B USD | 61 | 48 | |
| 116 | 5.76T KRW (≈$4.1B) | 61 | 59 | |
| 117 | 5.3B USD | 60 | 50 | |
| 118 | 34.2B CNY (≈$4.8B) | 60 | 59 | |
| 119 | 3.5B USD | 59 | 75 | |
| 120 | 3.2B USD | 59 | 65 | |
| 121 | 14.0B CNY (≈$2.0B) | 59 | 40 | |
| 122 | 3.4B USD | 58 | 55 | |
| 123 | 5.0B USD | 58 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score